Qianhuan Huang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background: Human epidermal growth factor receptor type 2 (HER2) is abundant in a wide variety of tumors and associated with the poor prognosis. Radiolabeled affibodies are potential candidates for detecting HER2-positive lesions. However, laborious multiple-step synthetic procedure and high abdomen background may hinder the widespread use. Herein,(More)
  • 1